Roger Murphy

2.2k total citations
25 papers, 873 citations indexed

About

Roger Murphy is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roger Murphy has authored 25 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roger Murphy's work include Immunotherapy and Immune Responses (8 papers), Receptor Mechanisms and Signaling (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Roger Murphy is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Receptor Mechanisms and Signaling (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Roger Murphy collaborates with scholars based in Australia, United States and Japan. Roger Murphy's co-authors include James A. Angus, Michael J. Lew, Andrew M. Scott, Lloyd J. Old, Paul K. Pallaghy, Raymond S. Norton, Hiroshi Shiku, Eric W. Hoffman, Kazunari Akiyoshi and Shinichi Kageyama and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Roger Murphy

24 papers receiving 843 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Murphy Australia 17 537 248 219 140 126 25 873
Giulia Guidotti Italy 8 794 1.5× 109 0.4× 67 0.3× 48 0.3× 68 0.5× 9 1.1k
George Thom United Kingdom 15 462 0.9× 117 0.5× 81 0.4× 189 1.4× 46 0.4× 22 722
Ruth M. Starzyk United States 15 597 1.1× 82 0.3× 106 0.5× 123 0.9× 62 0.5× 34 1.1k
Maggie Kozman United States 6 420 0.8× 70 0.3× 99 0.5× 53 0.4× 39 0.3× 6 775
Fengqin Miao China 17 297 0.6× 304 1.2× 133 0.6× 27 0.2× 42 0.3× 53 795
Colin V. Gegg United States 12 461 0.9× 119 0.5× 86 0.4× 142 1.0× 55 0.4× 17 728
Yichao Lu China 20 1.1k 2.0× 310 1.3× 171 0.8× 25 0.2× 39 0.3× 48 1.7k
Amy Winans United States 6 261 0.5× 111 0.4× 69 0.3× 15 0.1× 44 0.3× 11 505
Chris Gordon United States 15 565 1.1× 141 0.6× 100 0.5× 127 0.9× 73 0.6× 32 979
Krishnakumar N. Menon India 15 343 0.6× 150 0.6× 66 0.3× 66 0.5× 56 0.4× 40 728

Countries citing papers authored by Roger Murphy

Since Specialization
Citations

This map shows the geographic impact of Roger Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Murphy more than expected).

Fields of papers citing papers by Roger Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Murphy. The network helps show where Roger Murphy may publish in the future.

Co-authorship network of co-authors of Roger Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Murphy. A scholar is included among the top collaborators of Roger Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Murphy. Roger Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herbertson, Rebecca, Niall C. Tebbutt, Fook-Thean Lee, et al.. (2014). Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine. Journal of Nuclear Medicine. 55(4). 534–539. 24 indexed citations
2.
Greenall, Sameer A., Ermanno Gherardi, Zhanqi Liu, et al.. (2012). Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET. PLoS ONE. 7(4). e34658–e34658. 25 indexed citations
3.
Perani, A., et al.. (2011). Impact on product quality of high productive GS-CHO cell lines. BMC Proceedings. 5(S8). P17–P17. 1 indexed citations
4.
Kageyama, Shinichi, Shigehisa Kitano, Yasuhiro Nagata, et al.. (2008). Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Science. 99(3). 601–607. 95 indexed citations
5.
Tsuji, Kazuhide, Akiko Uenaka, Hisashi Wada, et al.. (2008). Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient. Cancer Immunology Immunotherapy. 57(10). 1429–1437. 37 indexed citations
6.
Wada, Hisashi, Eiichi Sato, Akiko Uenaka, et al.. (2008). Analysis of peripheral and local anti‐tumor immune response in esophageal cancer patients after NY‐ESO‐1 protein vaccination. International Journal of Cancer. 123(10). 2362–2369. 31 indexed citations
7.
Kawabata, Ryohei, Hisashi Wada, Midori Isobe, et al.. (2007). Antibody response against NY‐ESO‐1 in CHP‐NY‐ESO‐1 vaccinated patients. International Journal of Cancer. 120(10). 2178–2184. 58 indexed citations
8.
Kitano, Shigehisa, Shinichi Kageyama, Yasuhiro Nagata, et al.. (2006). HER2-Specific T-Cell Immune Responses in Patients Vaccinated with Truncated HER2 Protein Complexed with Nanogels of Cholesteryl Pullulan. Clinical Cancer Research. 12(24). 7397–7405. 103 indexed citations
9.
10.
Liu, Zhanqi, Con Panousis, Fiona E. Smyth, et al.. (2003). Generation of Anti-Idiotype Antibodies for Application in Clinical Immunotherapy Laboratory Analyses. PubMed. 22(4). 219–228. 20 indexed citations
11.
Achen, Marc G., Sally Roufail, Teresa Domagała, et al.. (2000). Monoclonal antibodies to vascular endothelial growth factor‐D block its interactions with both VEGF receptor‐2 and VEGF receptor‐3. European Journal of Biochemistry. 267(9). 2505–2515. 94 indexed citations
12.
Pallaghy, Paul K., et al.. (1999). Role of disulfide bridges in the folding, structure and biological activity of ω-conotoxin GVIA. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1434(1). 177–190. 28 indexed citations
13.
Pallaghy, Paul K., et al.. (1999). Roles of key functional groups in ω‐conotoxin GVIA. European Journal of Biochemistry. 262(2). 447–455. 44 indexed citations
14.
Lew, Michael J., Paul K. Pallaghy, Roger Murphy, et al.. (1997). Structure-Function Relationships of ω-Conotoxin GVIA. Journal of Biological Chemistry. 272(18). 12014–12023. 84 indexed citations
15.
Lew, Michael J., Roger Murphy, & James A. Angus. (1996). Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors. British Journal of Pharmacology. 117(8). 1768–1772. 24 indexed citations
16.
Marley, Philip D., et al.. (1996). Activation of tyrosine hydroxylase by pituitary adenylate cyclase-activating polypeptide (PACAP-27) in bovine adrenal chromaffin cells. Journal of the Autonomic Nervous System. 60(3). 141–146. 32 indexed citations
17.
Southwell, Bridget R., et al.. (1996). Characterisation of substance P-induced endocytosis of NK1 receptors on enteric neurons. Histochemistry and Cell Biology. 106(6). 563–571. 41 indexed citations
18.
Murphy, Roger, et al.. (1995). Synthesis and biological characterisation of a series of iberiotoxin analogues. International journal of peptide & protein research. 45(4). 320–325. 7 indexed citations
19.
Murphy, Roger, et al.. (1995). Synthesis and biological characterization of a series of analogues of ω‐conotoxin gvia. Journal of Peptide Science. 1(6). 379–384. 10 indexed citations
20.
Murphy, Roger, et al.. (1988). The impact of graded tests. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Guidotti Breakdown of academic impact, for papers by George Thom Breakdown of academic impact, for papers by Ruth M. Starzyk Breakdown of academic impact, for papers by Maggie Kozman Breakdown of academic impact, for papers by Fengqin Miao Breakdown of academic impact, for papers by Colin V. Gegg Breakdown of academic impact, for papers by Yichao Lu Breakdown of academic impact, for papers by Amy Winans Breakdown of academic impact, for papers by Chris Gordon Breakdown of academic impact, for papers by Krishnakumar N. Menon
Rankless by CCL
2026